Erlangen, Germany

Alexander Brost

This inventor holds 13 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Siemens Healthcare Gmbh, Siemens Aktiengesellschaft, Siemens Healthineers Ag. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Brost. Retrieved from https://idiyas.com/inventor/alexander-brost

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 84.6

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Alexander Brost - Innovative Inventor from Erlangen

Introduction: Alexander Brost is a renowned inventor based in Erlangen, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Alexander Brost holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Alexander Brost has worked with leading research institutions and companies to develop cutting-edge technologies that have had a significant impact on society.

Collaborations: Throughout his career, Alexander Brost has collaborated with top universities, research institutions, and multinational corporations to bring his innovative ideas to life and push the boundaries of technological advancement.

Conclusion: Alexander Brost's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global technological landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…